Global Oncology NGS Databank Market Report
The Oncology NGS market was valued at $376.2 Million in 2022, and is projected to reach $1,143.6 Million by 2031 growing at a CAGR of 13.22% from 2023 to 2031. Targeted Sequencing & Resequencing segment is expected to be the highest contributor to this market, with $242.5 Million in 2022, and is anticipated to reach $709.3 Million by 2031, registering a CAGR of 12.73%. Whole Genome Sequencing segment is anticipated to reach $75.1 Million by 2031 with the highest CAGR of 14.43%. Targeted Sequencing & Resequencing and Whole Exome Sequencing segments collectively expected to account for about 94.0% share of the Oncology NGS market in 2022, with the former constituting around 64.5% share. Whole Genome Sequencing and Whole Exome Sequencing segments are expected to witness significant growth rates at a CAGR of 14.43% and 13.98% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 35.5% in the overall Oncology NGS market in 2022, and is anticipated to reach 38.0% by 2031.
- 1. Global Oncology NGS Market, By Technology
- 1.1. Overview
- 1.2. Whole Genome Sequencing
- 1.2.1 Whole Genome Sequencing Market, By Region
- 1.2.1.1 North America Whole Genome Sequencing Market, By Country
- 1.2.1.2 Europe Whole Genome Sequencing Market, By Country
- 1.2.1.3 Asia-Pacific Whole Genome Sequencing Market, By Country
- 1.2.1.4 Rest of World Whole Genome Sequencing Market, By Country
- 1.3. Whole Exome Sequencing
- 1.3.1 Whole Exome Sequencing Market, By Region
- 1.3.1.1 North America Whole Exome Sequencing Market, By Country
- 1.3.1.2 Europe Whole Exome Sequencing Market, By Country
- 1.3.1.3 Asia-Pacific Whole Exome Sequencing Market, By Country
- 1.3.1.4 Rest of World Whole Exome Sequencing Market, By Country
- 1.4. Targeted Sequencing & Resequencing
- 1.4.1 Targeted Sequencing & Resequencing Market, By Region
- 1.4.1.1 North America Targeted Sequencing & Resequencing Market, By Country
- 1.4.1.2 Europe Targeted Sequencing & Resequencing Market, By Country
- 1.4.1.3 Asia-Pacific Targeted Sequencing & Resequencing Market, By Country
- 1.4.1.4 Rest of World Targeted Sequencing & Resequencing Market, By Country
- 2. Global Oncology NGS Market, By Workflow
- 2.1. Overview
- 2.2. NGS Pre-Sequencing
- 2.2.1 NGS Pre-Sequencing Market, By Region
- 2.2.1.1 North America NGS Pre-Sequencing Market, By Country
- 2.2.1.2 Europe NGS Pre-Sequencing Market, By Country
- 2.2.1.3 Asia-Pacific NGS Pre-Sequencing Market, By Country
- 2.2.1.4 Rest of World NGS Pre-Sequencing Market, By Country
- 2.3. NGS Sequencing
- 2.3.1 NGS Sequencing Market, By Region
- 2.3.1.1 North America NGS Sequencing Market, By Country
- 2.3.1.2 Europe NGS Sequencing Market, By Country
- 2.3.1.3 Asia-Pacific NGS Sequencing Market, By Country
- 2.3.1.4 Rest of World NGS Sequencing Market, By Country
- 2.4. NGS Data Analysis
- 2.4.1 NGS Data Analysis Market, By Region
- 2.4.1.1 North America NGS Data Analysis Market, By Country
- 2.4.1.2 Europe NGS Data Analysis Market, By Country
- 2.4.1.3 Asia-Pacific NGS Data Analysis Market, By Country
- 2.4.1.4 Rest of World NGS Data Analysis Market, By Country
- 3. Global Oncology NGS Market, By Application
- 3.1. Overview
- 3.2. Screening
- 3.2.1 Screening Market, By Region
- 3.2.1.1 North America Screening Market, By Country
- 3.2.1.2 Europe Screening Market, By Country
- 3.2.1.3 Asia-Pacific Screening Market, By Country
- 3.2.1.4 Rest of World Screening Market, By Country
- 3.3. Companion Diagnostics
- 3.3.1 Companion Diagnostics Market, By Region
- 3.3.1.1 North America Companion Diagnostics Market, By Country
- 3.3.1.2 Europe Companion Diagnostics Market, By Country
- 3.3.1.3 Asia-Pacific Companion Diagnostics Market, By Country
- 3.3.1.4 Rest of World Companion Diagnostics Market, By Country
- 3.4. Other Diagnostics
- 3.4.1 Other Diagnostics Market, By Region
- 3.4.1.1 North America Other Diagnostics Market, By Country
- 3.4.1.2 Europe Other Diagnostics Market, By Country
- 3.4.1.3 Asia-Pacific Other Diagnostics Market, By Country
- 3.4.1.4 Rest of World Other Diagnostics Market, By Country
- 4. Global Oncology NGS Market, By End-use
- 4.1. Overview
- 4.2. Hospitals
- 4.2.1 Hospitals Market, By Region
- 4.2.1.1 North America Hospitals Market, By Country
- 4.2.1.2 Europe Hospitals Market, By Country
- 4.2.1.3 Asia-Pacific Hospitals Market, By Country
- 4.2.1.4 Rest of World Hospitals Market, By Country
- 4.3. Clinics
- 4.3.1 Clinics Market, By Region
- 4.3.1.1 North America Clinics Market, By Country
- 4.3.1.2 Europe Clinics Market, By Country
- 4.3.1.3 Asia-Pacific Clinics Market, By Country
- 4.3.1.4 Rest of World Clinics Market, By Country
- 4.4. Laboratories
- 4.4.1 Laboratories Market, By Region
- 4.4.1.1 North America Laboratories Market, By Country
- 4.4.1.2 Europe Laboratories Market, By Country
- 4.4.1.3 Asia-Pacific Laboratories Market, By Country
- 4.4.1.4 Rest of World Laboratories Market, By Country
- 5. Global Oncology NGS Market, By Region
- 5.1. Overview
- 5.2. North America
- 5.2.1 North America Oncology NGS Market, By Technology
- 5.2.2 North America Oncology NGS Market, By Workflow
- 5.2.3 North America Oncology NGS Market, By Application
- 5.2.4 North America Oncology NGS Market, By End-use
- 5.2.5 North America Oncology NGS Market, By Country
- 5.2.5.1 U.S.
- 5.2.5.1.1 U.S. Oncology NGS Market, By Technology
- 5.2.5.1.2 U.S. Oncology NGS Market, By Workflow
- 5.2.5.1.3 U.S. Oncology NGS Market, By Application
- 5.2.5.1.4 U.S. Oncology NGS Market, By End-use
- 5.2.5.2 Canada
- 5.2.5.2.1 Canada Oncology NGS Market, By Technology
- 5.2.5.2.2 Canada Oncology NGS Market, By Workflow
- 5.2.5.2.3 Canada Oncology NGS Market, By Application
- 5.2.5.2.4 Canada Oncology NGS Market, By End-use
- 5.3. Europe
- 5.3.1 Europe Oncology NGS Market, By Technology
- 5.3.2 Europe Oncology NGS Market, By Workflow
- 5.3.3 Europe Oncology NGS Market, By Application
- 5.3.4 Europe Oncology NGS Market, By End-use
- 5.3.5 Europe Oncology NGS Market, By Country
- 5.3.5.1 Germany
- 5.3.5.1.1 Germany Oncology NGS Market, By Technology
- 5.3.5.1.2 Germany Oncology NGS Market, By Workflow
- 5.3.5.1.3 Germany Oncology NGS Market, By Application
- 5.3.5.1.4 Germany Oncology NGS Market, By End-use
- 5.3.5.2 U.K.
- 5.3.5.2.1 U.K. Oncology NGS Market, By Technology
- 5.3.5.2.2 U.K. Oncology NGS Market, By Workflow
- 5.3.5.2.3 U.K. Oncology NGS Market, By Application
- 5.3.5.2.4 U.K. Oncology NGS Market, By End-use
- 5.3.5.3 France
- 5.3.5.3.1 France Oncology NGS Market, By Technology
- 5.3.5.3.2 France Oncology NGS Market, By Workflow
- 5.3.5.3.3 France Oncology NGS Market, By Application
- 5.3.5.3.4 France Oncology NGS Market, By End-use
- 5.3.5.4 Italy
- 5.3.5.4.1 Italy Oncology NGS Market, By Technology
- 5.3.5.4.2 Italy Oncology NGS Market, By Workflow
- 5.3.5.4.3 Italy Oncology NGS Market, By Application
- 5.3.5.4.4 Italy Oncology NGS Market, By End-use
- 5.3.5.5 Spain
- 5.3.5.5.1 Spain Oncology NGS Market, By Technology
- 5.3.5.5.2 Spain Oncology NGS Market, By Workflow
- 5.3.5.5.3 Spain Oncology NGS Market, By Application
- 5.3.5.5.4 Spain Oncology NGS Market, By End-use
- 5.3.5.6 Rest of Europe
- 5.3.5.6.1 Rest of Europe Oncology NGS Market, By Technology
- 5.3.5.6.2 Rest of Europe Oncology NGS Market, By Workflow
- 5.3.5.6.3 Rest of Europe Oncology NGS Market, By Application
- 5.3.5.6.4 Rest of Europe Oncology NGS Market, By End-use
- 5.4. Asia-Pacific
- 5.4.1 Asia-Pacific Oncology NGS Market, By Technology
- 5.4.2 Asia-Pacific Oncology NGS Market, By Workflow
- 5.4.3 Asia-Pacific Oncology NGS Market, By Application
- 5.4.4 Asia-Pacific Oncology NGS Market, By End-use
- 5.4.5 Asia-Pacific Oncology NGS Market, By Country
- 5.4.5.1 China
- 5.4.5.1.1 China Oncology NGS Market, By Technology
- 5.4.5.1.2 China Oncology NGS Market, By Workflow
- 5.4.5.1.3 China Oncology NGS Market, By Application
- 5.4.5.1.4 China Oncology NGS Market, By End-use
- 5.4.5.2 Japan
- 5.4.5.2.1 Japan Oncology NGS Market, By Technology
- 5.4.5.2.2 Japan Oncology NGS Market, By Workflow
- 5.4.5.2.3 Japan Oncology NGS Market, By Application
- 5.4.5.2.4 Japan Oncology NGS Market, By End-use
- 5.4.5.3 South Korea
- 5.4.5.3.1 South Korea Oncology NGS Market, By Technology
- 5.4.5.3.2 South Korea Oncology NGS Market, By Workflow
- 5.4.5.3.3 South Korea Oncology NGS Market, By Application
- 5.4.5.3.4 South Korea Oncology NGS Market, By End-use
- 5.4.5.4 India
- 5.4.5.4.1 India Oncology NGS Market, By Technology
- 5.4.5.4.2 India Oncology NGS Market, By Workflow
- 5.4.5.4.3 India Oncology NGS Market, By Application
- 5.4.5.4.4 India Oncology NGS Market, By End-use
- 5.4.5.5 Singapore
- 5.4.5.5.1 Singapore Oncology NGS Market, By Technology
- 5.4.5.5.2 Singapore Oncology NGS Market, By Workflow
- 5.4.5.5.3 Singapore Oncology NGS Market, By Application
- 5.4.5.5.4 Singapore Oncology NGS Market, By End-use
- 5.4.5.6 Rest of Asia
- 5.4.5.6.1 Rest of Asia Oncology NGS Market, By Technology
- 5.4.5.6.2 Rest of Asia Oncology NGS Market, By Workflow
- 5.4.5.6.3 Rest of Asia Oncology NGS Market, By Application
- 5.4.5.6.4 Rest of Asia Oncology NGS Market, By End-use
- 5.5. Rest of World
- 5.5.1 Rest of World Oncology NGS Market, By Technology
- 5.5.2 Rest of World Oncology NGS Market, By Workflow
- 5.5.3 Rest of World Oncology NGS Market, By Application
- 5.5.4 Rest of World Oncology NGS Market, By End-use
- 5.5.5 Rest of World Oncology NGS Market, By Country
- 5.5.5.1 Brazil
- 5.5.5.1.1 Brazil Oncology NGS Market, By Technology
- 5.5.5.1.2 Brazil Oncology NGS Market, By Workflow
- 5.5.5.1.3 Brazil Oncology NGS Market, By Application
- 5.5.5.1.4 Brazil Oncology NGS Market, By End-use
- 5.5.5.2 Mexico
- 5.5.5.2.1 Mexico Oncology NGS Market, By Technology
- 5.5.5.2.2 Mexico Oncology NGS Market, By Workflow
- 5.5.5.2.3 Mexico Oncology NGS Market, By Application
- 5.5.5.2.4 Mexico Oncology NGS Market, By End-use
- 5.5.5.3 South Africa
- 5.5.5.3.1 South Africa Oncology NGS Market, By Technology
- 5.5.5.3.2 South Africa Oncology NGS Market, By Workflow
- 5.5.5.3.3 South Africa Oncology NGS Market, By Application
- 5.5.5.3.4 South Africa Oncology NGS Market, By End-use
- 5.5.5.4 Australia
- 5.5.5.4.1 Australia Oncology NGS Market, By Technology
- 5.5.5.4.2 Australia Oncology NGS Market, By Workflow
- 5.5.5.4.3 Australia Oncology NGS Market, By Application
- 5.5.5.4.4 Australia Oncology NGS Market, By End-use
- 5.5.5.5 ROW Countries
- 5.5.5.5.1 ROW Countries Oncology NGS Market, By Technology
- 5.5.5.5.2 ROW Countries Oncology NGS Market, By Workflow
- 5.5.5.5.3 ROW Countries Oncology NGS Market, By Application
- 5.5.5.5.4 ROW Countries Oncology NGS Market, By End-use
- ROW Countries Oncology NGS Market Value, By End-use, 2022-2031, Million USD LIST OF TABLES
- TABLE 1. Global Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 2. Whole Genome Sequencing Market Value, By Region, 2022-2031, Million USD
- TABLE 3. North America Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 4. Europe Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 5. Asia-Pacific Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 6. Rest of World Whole Genome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 7. Whole Exome Sequencing Market Value, By Region, 2022-2031, Million USD
- TABLE 8. North America Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 9. Europe Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 10. Asia-Pacific Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 11. Rest of World Whole Exome Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 12. Targeted Sequencing & Resequencing Market Value, By Region, 2022-2031, Million USD
- TABLE 13. North America Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 14. Europe Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 15. Asia-Pacific Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 16. Rest of World Targeted Sequencing & Resequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 17. Global Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 18. NGS Pre-Sequencing Market Value, By Region, 2022-2031, Million USD
- TABLE 19. North America NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 20. Europe NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 21. Asia-Pacific NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 22. Rest of World NGS Pre-Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 23. NGS Sequencing Market Value, By Region, 2022-2031, Million USD
- TABLE 24. North America NGS Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 25. Europe NGS Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 26. Asia-Pacific NGS Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 27. Rest of World NGS Sequencing Market Value, By Country, 2022-2031, Million USD
- TABLE 28. NGS Data Analysis Market Value, By Region, 2022-2031, Million USD
- TABLE 29. North America NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 30. Europe NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 31. Asia-Pacific NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 32. Rest of World NGS Data Analysis Market Value, By Country, 2022-2031, Million USD
- TABLE 33. Global Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 34. Screening Market Value, By Region, 2022-2031, Million USD
- TABLE 35. North America Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 36. Europe Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 37. Asia-Pacific Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 38. Rest of World Screening Market Value, By Country, 2022-2031, Million USD
- TABLE 39. Companion Diagnostics Market Value, By Region, 2022-2031, Million USD
- TABLE 40. North America Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 41. Europe Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 42. Asia-Pacific Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 43. Rest of World Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 44. Other Diagnostics Market Value, By Region, 2022-2031, Million USD
- TABLE 45. North America Other Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 46. Europe Other Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 47. Asia-Pacific Other Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 48. Rest of World Other Diagnostics Market Value, By Country, 2022-2031, Million USD
- TABLE 49. Global Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 50. Hospitals Market Value, By Region, 2022-2031, Million USD
- TABLE 51. North America Hospitals Market Value, By Country, 2022-2031, Million USD
- TABLE 52. Europe Hospitals Market Value, By Country, 2022-2031, Million USD
- TABLE 53. Asia-Pacific Hospitals Market Value, By Country, 2022-2031, Million USD
- TABLE 54. Rest of World Hospitals Market Value, By Country, 2022-2031, Million USD
- TABLE 55. Clinics Market Value, By Region, 2022-2031, Million USD
- TABLE 56. North America Clinics Market Value, By Country, 2022-2031, Million USD
- TABLE 57. Europe Clinics Market Value, By Country, 2022-2031, Million USD
- TABLE 58. Asia-Pacific Clinics Market Value, By Country, 2022-2031, Million USD
- TABLE 59. Rest of World Clinics Market Value, By Country, 2022-2031, Million USD
- TABLE 60. Laboratories Market Value, By Region, 2022-2031, Million USD
- TABLE 61. North America Laboratories Market Value, By Country, 2022-2031, Million USD
- TABLE 62. Europe Laboratories Market Value, By Country, 2022-2031, Million USD
- TABLE 63. Asia-Pacific Laboratories Market Value, By Country, 2022-2031, Million USD
- TABLE 64. Rest of World Laboratories Market Value, By Country, 2022-2031, Million USD
- TABLE 65. Global Oncology NGS Market Value, By Region, 2022-2031, Million USD
- TABLE 66. North America Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 67. North America Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 68. North America Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 69. North America Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 70. North America Oncology NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 71. U.S. Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 72. U.S. Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 73. U.S. Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 74. U.S. Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 75. Canada Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 76. Canada Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 77. Canada Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 78. Canada Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 79. Europe Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 80. Europe Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 81. Europe Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 82. Europe Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 83. Europe Oncology NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 84. Germany Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 85. Germany Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 86. Germany Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 87. Germany Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 88. U.K. Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 89. U.K. Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 90. U.K. Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 91. U.K. Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 92. France Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 93. France Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 94. France Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 95. France Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 96. Italy Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 97. Italy Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 98. Italy Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 99. Italy Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 100. Spain Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 101. Spain Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 102. Spain Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 103. Spain Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 104. Rest of Europe Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 105. Rest of Europe Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 106. Rest of Europe Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 107. Rest of Europe Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 108. Asia-Pacific Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 109. Asia-Pacific Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 110. Asia-Pacific Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 111. Asia-Pacific Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 112. Asia-Pacific Oncology NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 113. China Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 114. China Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 115. China Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 116. China Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 117. Japan Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 118. Japan Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 119. Japan Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 120. Japan Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 121. South Korea Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 122. South Korea Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 123. South Korea Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 124. South Korea Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 125. India Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 126. India Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 127. India Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 128. India Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 129. Singapore Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 130. Singapore Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 131. Singapore Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 132. Singapore Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 133. Rest of Asia Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 134. Rest of Asia Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 135. Rest of Asia Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 136. Rest of Asia Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 137. Rest of World Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 138. Rest of World Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 139. Rest of World Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 140. Rest of World Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 141. Rest of World Oncology NGS Market Value, By Country, 2022-2031, Million USD
- TABLE 142. Brazil Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 143. Brazil Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 144. Brazil Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 145. Brazil Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 146. Mexico Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 147. Mexico Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 148. Mexico Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 149. Mexico Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 150. South Africa Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 151. South Africa Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 152. South Africa Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 153. South Africa Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 154. Australia Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 155. Australia Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 156. Australia Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 157. Australia Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- TABLE 158. ROW Countries Oncology NGS Market Value, By Technology, 2022-2031, Million USD
- TABLE 159. ROW Countries Oncology NGS Market Value, By Workflow, 2022-2031, Million USD
- TABLE 160. ROW Countries Oncology NGS Market Value, By Application, 2022-2031, Million USD
- TABLE 161. ROW Countries Oncology NGS Market Value, By End-use, 2022-2031, Million USD
- ROW Countries Oncology NGS Market Value, By End-use, 2022-2031, Million USD
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook